Stanley Y Au, Age 4811118 Woodson Ave, Kensington, MD 20895

Stanley Au Phones & Addresses

11118 Woodson Ave, Kensington, MD 20895

Bethesda, MD

Danbury, CT

190 72Nd St APT 129, Brooklyn, NY 11209 (718) 836-1382

190 72Nd St, Brooklyn, NY 11209

San Francisco, CA

Buffalo, NY

Show more

Mentions for Stanley Y Au

Stanley Au resumes & CV records

Resumes

Stanley Au Photo 30

Software Analyst At Genesys

Position:
Software Analyst at Genesys
Location:
Richmond Hill, Ontario, Canada
Industry:
Computer Software
Work:
Genesys since Jun 2012
Software Analyst
Demonware - Vancouver, British Columbia Aug 2011 - Dec 2012
CSI LiveOps Intern
Arista Networks, Inc. Jan 2011 - Apr 2011
Manufacturing Engineering
MTS Allstream May 2010 - Aug 2010
Co-op Student, Technology
AMD Aug 2009 - Dec 2009
Co-op Engineer
Scotiabank Apr 2008 - Aug 2008
Technical Network Analyst
Education:
University of Waterloo 2007 - 2012
BASc, Engineering
Skills:
Python, Java, Debugging, SQL, C#, Database Design, JSON, C++, C, Git, Linux, Programming, MySQL, Mercurial
Stanley Au Photo 31

Test Engineer At Csc

Location:
Washington D.C. Metro Area
Industry:
Computer & Network Security

Publications & IP owners

Us Patents

Sustained Release Formulations Of Nalbuphine

US Patent:
2009003, Jan 29, 2009
Filed:
May 23, 2008
Appl. No.:
12/154496
Inventors:
Anand R. Baichwal - Wappingers Falls NY, US
Philip A. Goliber - Lasne, BE
Anthony E. Carpanzano - New Milford CT, US
Thomas Sciascia - Belmont MA, US
Donald Diehl, II - New Fairfield CT, US
Brian Vogler - North White Plains NY, US
David Verbel - New York NY, US
Stanley Au - Bethesda MD, US
International Classification:
A61K 31/485
A61P 25/00
US Classification:
514282
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Sustained Release Formulation Of Nalbuphine

US Patent:
2013016, Jun 27, 2013
Filed:
Feb 21, 2013
Appl. No.:
13/773136
Inventors:
PHILIP A. GOLIBER - LASNE, BE
ANTHONY E. CARPANZANO - NEW MILFORD CT, US
THOMAS SCIASCIA - BELMONT MA, US
DONALD DIEHL, II - NEW FAIRFIELD CT, US
BRIAN VOGLER - NORTH WHITE PLAINS NY, US
DAVID VERBEL - NEW YORK NY, US
STANLEY AU - BETHESDA MD, US
Assignee:
PENWEST PHARMACEUTICALS CO. - CHADDS FORD PA
International Classification:
A61K 9/00
US Classification:
424400, 514282
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Sustained Release Formulation Of Nalbuphine

US Patent:
2018004, Feb 15, 2018
Filed:
Jul 24, 2017
Appl. No.:
15/658234
Inventors:
- Malvern PA, US
Philip A. GOLIBER - Lasne, BE
Anthony E. CARPANZANO - New Milford CT, US
Thomas SCIASCIA - Belmont MA, US
Donald DIEHL, II - New Fairfield CT, US
Brian VOGLER - North White Plains NY, US
David VERBEL - New York NY, US
Stanley AU - Bethesda MD, US
International Classification:
A61K 9/20
A61K 9/00
A61K 9/24
A61K 31/485
A61K 9/28
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Sustained Release Formulation Of Nalbuphine

US Patent:
2016026, Sep 15, 2016
Filed:
May 23, 2016
Appl. No.:
15/162062
Inventors:
- Malvern PA, US
Philip A. Goliber - Lasne, BE
Anthony E. Carpanzano - New Milford CT, US
Thomas Sciascia - Belmont MA, US
Donald Diehl - New Fairfield CT, US
Brian Vogler - North White Plains NY, US
David Verbel - New York NY, US
Stanley Au - Bethesda MD, US
Assignee:
Endo Pharmaceuticals Inc. - Malvern PA
International Classification:
A61K 9/20
A61K 31/485
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Sustained Release Formulation Of Nalbuphine

US Patent:
2014027, Sep 18, 2014
Filed:
May 29, 2014
Appl. No.:
14/290413
Inventors:
- Chadds Ford PA, US
Philip A. GOLIBER - Lasne, BE
Anthony E. CARPANZANO - New Milford CT, US
Thomas SCIASCIA - Belmont MA, US
Donald DIEHL, II - New Fairfield CT, US
Brian VOGLER - North White Plains NY, US
David VERBEL - New York NY, US
Stanley AU - Bethesda MD, US
Assignee:
PENWEST PHARMACEUTICALS CO. - Chadds Ford PA
International Classification:
A61K 9/28
A61K 31/485
US Classification:
424472, 514282, 424468
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.